SpotLight™
A 30-second, non-invasive optical biosignature screening platform. Real-time biological insights across multiple indications.
SpotLight-C™
Cancer Screening
SpotLight-C™ is under development for non-invasive early-stage cancer detection and real-time chemotherapy response monitoring.
Selected for the 2026 Mayo Clinic & ASU Health Care Accelerator.
SpotLight-19™
Pathogen Detection
SpotLight-19™ was developed during the COVID-19 pandemic and is being expanded to include a range of pathogens, without the need for a biological sample. A 30-second, non-invasive screening test designed for rapid, scalable deployment at point of care.
Invited as participant in the National Security Commission on Emerging Biotechnology Arizona Summit.